HHS Secretary Robert F. Kennedy, Jr. Testifies on Budget

This was a congressional hearing held on April 22, 2026, featuring testimony from HHS Secretary Robert F. Kennedy Jr. regarding the administration's proposed 2027 budget for the Department of Health and Human Services. The discussion focused heavily on healthcare affordability, drug pricing reforms, and accelerating drug approvals, with Secretary Kennedy highlighting initiatives such as price transparency bills, prior authorization reforms, and the use of AI to speed FDA drug review processes. The Secretary also addressed budget cuts proposed for NIH and CDC, rural health investments including a $50 billion Rural Health Transformation Fund, and efforts to improve nutrition education and food labeling. Several senators raised concerns about reductions in funding for vaccine research, public health programs, and disability services, as well as the impact of Medicaid funding changes on rural hospital closures. The hearing included debates on abortion drug policies, vaccine safety, and chronic disease prevention. No specific contract awards or procurement actions were detailed, but the budget discussions and policy proposals could influence future procurement and funding priorities within HHS.